title: American Urological Association and European Association of Urology guidelines in the management of benign prostatic hypertrophy:  revisited.
abstract: OBJECTIVE
  The purpose of this review is to provide a complete revision of two of the most widely used clinical guidelines in the management of lower urinary tract symptoms induced by benign prostatic hyperplasia and their importance and compliance among urologists.
  
  
  RESULTS
  Updates of the American Association of Urology and European Association of Urology clinical practice guidelines (CPGs) were reviewed and analyzed. Literature concerning compliance and application of these two CPGs in the different working scenarios of practicing has been evaluated.
  
  
  CONCLUSIONS
  Urology has moved to an era in which costs and quality of care are being scrutinized, and compliance to CPGs will be assessed. Practicing urologists do not have the time to keep up to date with the continuous incoming literature and CPGs are a great tool to give the highest quality of care to our patients.
authors: UROCENTRO Medical Center, Barranquilla, Colombia. armando.juliao@me.com
authors: Armando A
authors: AA
authors: Juliao
authors: Mauricio
authors: M
authors: Plata
authors: Amir
authors: A
authors: Kazzazi
authors: Yakup
authors: Y
authors: Bostanci
authors: Bob
authors: B
authors: Djavan
mesh_terms: D005060:Europe; D019317:Evidence-Based Medicine / Q000592:standards; D019983:Guideline Adherence; D006801:Humans; D059411:Lower Urinary Tract Symptoms / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D008297:Male; D017410:Practice Guidelines as Topic / Q000592:standards*; D010818:Practice Patterns, Physicians' / Q000592:standards; D011470:Prostatic Hyperplasia / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D011787:Quality of Health Care / Q000592:standards; D012955:Societies, Medical / Q000592:standards*; D014481:United States; D014572:Urology / Q000592:standards*